Clinical Trial Update: Correlation of FC Gamma RIIIA Receptor Response in Patients With Waldenstrom's Macroglobulinemia [NA]

View source ↗

Summary

A completed clinical trial update examining the correlation of Fc Gamma RIIIA (CD16) receptor response in patients with Waldenström macroglobulinemia. The study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Waldenström Macroglobulinemia

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Waldenstrom's Macroglobulinemia | NA | Status: COMPLETED